Results 71 to 79 of about 634 (79)

Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review

Biomedicine and Pharmacotherapy, 2023
, Ida M Heerfordt, Peter A Philipsen
exaly  

Association of quality of life measures with afamelanotide treatment in patients with erythropoietic protoporphyria and x-linked protoporphyria: A retrospective cohort study

Journal of the American Academy of Dermatology, 2023
Tasneem Mohammad, Henry Wan-Peng Lim, Dayoung Ko   +2 more
exaly  

Prospective observational pilot study of quantitative light dosimetry in erythropoietic protoporphyria

Journal of the American Academy of Dermatology, 2023
Sarina B Elmariah
exaly  

X‐linked dominant protoporphyria: The first reported Japanese case

Journal of Dermatology, 2016
Hideaki Tanizaki, Shinichi Moriwaki
exaly  

Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients

Biochimica Et Biophysica Acta - Molecular Basis of Disease, 2017
Gloria C Ferreira, Laurent Gouya, Vladimir Uversky   +2 more
exaly  

Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria

Pharmaceuticals
, Katelyn Madigan, Bonkovsky Herbert L
exaly  

Late-Onset X-Linked Dominant Protoporphyria: An Etiology of Photosensitivity in the Elderly

Journal of Investigative Dermatology, 2013
Laurence Lamant, Laurent Gouya, Cristina Bulai Livideanu   +2 more
exaly